Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W J Chng

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Leukemia|February 13, 2013
Type II EATL (epitheliotropic intestinal T-cell lymphoma): a neoplasm of intra-epithelial T-cells with predominant CD8αα phenotypeS-Y Tan, S-S Chuang, T Tang, et al.
Bone Marrow Transplantation|March 15, 2016
Early relapse post autologous transplant is a stronger predictor of survival compared with pretreatment patient factors in the novel agent era: analysis of the Singapore Multiple Myeloma Working GroupS Y Ong, S de Mel, Y X Chen, et al.
Leukemia|March 3, 2006
Prognostic factors for hyperdiploid-myeloma: effects of chromosome 13 deletions and IgH translocationsW J Chng, R Santana-Dávila, S A Van Wier, et al.
Leukemia|December 28, 2016
Carfilzomib-dexamethasone vs bortezomib-dexamethasone in relapsed or refractory multiple myeloma by cytogenetic risk in the phase 3 study ENDEAVORW-J Chng, H Goldschmidt, M A Dimopoulos, et al.
Leukemia|August 6, 2016
Impact of prior treatment on patients with relapsed multiple myeloma treated with carfilzomib and dexamethasone vs bortezomib and dexamethasone in the phase 3 ENDEAVOR studyP Moreau, D Joshua, W-J Chng, et al.
Leukemia|January 25, 2008
Genetic aberrations and survival in plasma cell leukemiaR E Tiedemann, N Gonzalez-Paz, R A Kyle, et al.
Leukemia Research|August 23, 2005
Ploidy status rarely changes in myeloma patients at disease progressionW J Chng, J M Winkler, P R Greipp, et al.
Leukemia|November 21, 2013
New drugs and novel mechanisms of action in multiple myeloma in 2013: a report from the International Myeloma Working Group (IMWG)E M Ocio, P G Richardson, S V Rajkumar, et al.
Leukemia|December 24, 2011
Management of treatment-emergent peripheral neuropathy in multiple myelomaP G Richardson, M Delforge, M Beksac, et al.
Leukemia|December 30, 2015
Management of relapsed multiple myeloma: recommendations of the International Myeloma Working GroupJ Laubach, L Garderet, A Mahindra, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Leukemia|February 13, 2013
Type II EATL (epitheliotropic intestinal T-cell lymphoma): a neoplasm of intra-epithelial T-cells with predominant CD8αα phenotypeS-Y Tan, S-S Chuang, T Tang, et al.
Bone Marrow Transplantation|March 15, 2016
Early relapse post autologous transplant is a stronger predictor of survival compared with pretreatment patient factors in the novel agent era: analysis of the Singapore Multiple Myeloma Working GroupS Y Ong, S de Mel, Y X Chen, et al.
Leukemia|March 3, 2006
Prognostic factors for hyperdiploid-myeloma: effects of chromosome 13 deletions and IgH translocationsW J Chng, R Santana-Dávila, S A Van Wier, et al.
Leukemia|December 28, 2016
Carfilzomib-dexamethasone vs bortezomib-dexamethasone in relapsed or refractory multiple myeloma by cytogenetic risk in the phase 3 study ENDEAVORW-J Chng, H Goldschmidt, M A Dimopoulos, et al.
Leukemia|August 6, 2016
Impact of prior treatment on patients with relapsed multiple myeloma treated with carfilzomib and dexamethasone vs bortezomib and dexamethasone in the phase 3 ENDEAVOR studyP Moreau, D Joshua, W-J Chng, et al.
Leukemia|January 25, 2008
Genetic aberrations and survival in plasma cell leukemiaR E Tiedemann, N Gonzalez-Paz, R A Kyle, et al.
Leukemia Research|August 23, 2005
Ploidy status rarely changes in myeloma patients at disease progressionW J Chng, J M Winkler, P R Greipp, et al.
Leukemia|November 21, 2013
New drugs and novel mechanisms of action in multiple myeloma in 2013: a report from the International Myeloma Working Group (IMWG)E M Ocio, P G Richardson, S V Rajkumar, et al.
Leukemia|December 24, 2011
Management of treatment-emergent peripheral neuropathy in multiple myelomaP G Richardson, M Delforge, M Beksac, et al.
Leukemia|December 30, 2015
Management of relapsed multiple myeloma: recommendations of the International Myeloma Working GroupJ Laubach, L Garderet, A Mahindra, et al.
Pageof 4